Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions

被引:69
|
作者
Lee, Jin Gu [1 ]
Shin, Ju Hye [2 ]
Shim, Hyo Sup [3 ]
Lee, Chang Young [1 ]
Kim, Dae Joon [1 ]
Kim, Young Sam [2 ]
Chung, Kyung Young [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
来源
RESPIRATORY RESEARCH | 2015年 / 16卷
关键词
Autophagy; Chemotherapy; Hypoxia; Lung cancer; Resistance; DECREASED EXPRESSION; TUMOR HYPOXIA; SURVIVAL; BECLIN-1; PROLIFERATION; PROTEINS; BNIP3; HIF-1; LC3;
D O I
10.1186/s12931-015-0285-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The development of chemo-resistance in non-small lung cancer is a major obstacle in treating patients. Hypoxia is a commonly faced microenvironment in solid tumor and suggested to be related to both autophagy and chemo-resistance. Methods: In this study, we investigated the role of hypoxia-induced autophagy in acquiring chemo-resistance in both cancer cell (A549) and human cancer tissue Results: Hypoxic exposure (1 % O2) of A549 cell stimulated autophagic induction in cancer cells, shown by increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 in Western blot, increased GFP-LC puncta in confocal microscopy, and increased number of double-membrane autophagic vacuoles in electron micrographs. Hypoxic exposure also induced resistance of cancer cells to cisplatin, and LC3B siRNA restored the sensitivity of cancer cells to chemotherapy. Furthermore, Human lung cancer tissues that experienced chemotherapy showed increase of LC3BI to LC3BII conversion and decrease of p62/sequestosome1 compared with chemo-naive cancer tissue in Western blot. Conclusion: Autophagy may play an important role in acquiring resistance to chemotherapy in lung cancer and hypoxia related pathway seems to be involved in autophagy induction.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer
    Yin, Jun
    Zhao, Jian
    Hu, Weimin
    Yang, Guangping
    Yu, Hui
    Wang, Ruihao
    Wang, Linjing
    Zhang, Guoqian
    Fu, Wenfan
    Dai, Lu
    Li, Wanzhen
    Liao, Boyu
    Zhang, Shuxu
    PLOS ONE, 2017, 12 (02):
  • [32] NOTCH-1 CONTRIBUTES TO EGFR-TKI ACQUIRED RESISTANCE IN NON-SMALL CELL LUNG CANCER
    Xie, M.
    Zhang, L.
    Xu, F.
    RESPIROLOGY, 2012, 17 : 89 - 89
  • [33] Neutrophil gelatinase associated lipocalin (NGAL) contributes to erlotinib resistance in non-small cell lung cancer (NSCLC)
    Cui, Xiaoyan
    Li, Zhu
    Krysan, Kostyantyn
    Luo, Jie
    Gardner, Brian
    Sharma, Sherven
    Dubinett, Steven M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S363 - S364
  • [34] Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer
    Krysan, Kostyantyn
    Cui, Xiaoyan
    Gardner, Brian K.
    Reckamp, Karen L.
    Wang, Xiaoyan
    Hong, Longsheng
    Walser, Tonya C.
    Rodriguez, Nicole L.
    Pagano, Paul C.
    Garon, Edward B.
    Brothers, John F., II
    Elashoff, David
    Lee, Jay M.
    Spira, Avrum E.
    Sharma, Sherven
    Fishbein, Michael C.
    Dubinett, Steven M.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2013, 5 (05): : 481 - 496
  • [35] The role of combination chemo-immunotherapy in advanced non-small cell lung cancer
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Gridelli, Cesare
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (07) : 561 - 568
  • [36] Use of chemo-radiotherapy in locally advanced non-small cell lung cancer
    Novello, S
    Le Chevalier, T
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) : 292 - 299
  • [37] Pneumonectomy after chemo- or chemoradiotherapy for advanced non-small cell lung cancer
    Collaud, S.
    Krbek, T.
    Hillinger, S.
    Fechner, S.
    Kestenholz, P.
    Stahel, R.
    Stamatis, G.
    Weder, W.
    SWISS MEDICAL WEEKLY, 2009, 139 (13-14) : 6S - 6S
  • [38] The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer
    Edahyr, Boshra
    Lind, Michael
    Karsera, Louise
    Mafi, Reza
    Wallace, Karen
    Howell, Gareth
    Hemmingway, Carl
    Stubbs, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1487 - S1488
  • [39] Non-small cell lung cancer: The role of surgery after induction chemo and/or radiotherapy
    Stamatelopoulos, A.
    Zaragkas, S.
    Sofoudis, C.
    JOURNAL OF BUON, 2010, 15 (02): : 213 - 220
  • [40] Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer
    Scotti, Vieri
    Saieva, Calogero
    Di Cataldo, Vanessa
    Bruni, Alessio
    Desideri, Isacco
    Bertocci, Silvia
    Meattini, Icro
    Livi, Lorenzo
    Simontacchi, Gabriele
    Cardillo, Carla De Luca
    Bendinelli, Benedetta
    Bastiani, Paolo
    Mangoni, Monica
    Agresti, Benedetta
    Biti, Giampaolo
    TUMORI, 2012, 98 (04) : 464 - 470